Viking Therapeutics
VKTX
#3594
Rank
โ‚ฌ2.46 B
Marketcap
21,96ย โ‚ฌ
Share price
-2.61%
Change (1 day)
-63.89%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2023 (TTM): -0,86ย โ‚ฌ

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,82ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,80ย โ‚ฌ a decrease over its 2021 EPS that were of -0,63ย โ‚ฌ.

EPS history for Viking Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,86ย โ‚ฌ8.02%
2022-0,80ย โ‚ฌ26.39%
2021-0,63ย โ‚ฌ33.33%
2020-0,47ย โ‚ฌ45.95%
2019-0,33ย โ‚ฌ-5.13%
2018-0,34ย โ‚ฌ-51.25%
2017-0,70ย โ‚ฌ-20%
2016-0,88ย โ‚ฌ-64.08%
2015-2,45ย โ‚ฌ-45.17%
2014-4,46ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-9,00ย โ‚ฌ 1,001.08%๐Ÿ‡บ๐Ÿ‡ธ USA
1,84ย โ‚ฌ-324.73%๐Ÿ‡บ๐Ÿ‡ธ USA